Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferritin light chain pseudogene 10 (FTLP10) is a member of the ferritin light chain pseudogene family. FTLP10 is annotated as a pseudogene, meaning it resembles a functional gene (Ferritin light chain/FTL), but it does not encode a functional protein product and is not involved in known biological pathways or diseases. Its presence in the genome does not confer any known therapeutic or biomarker relevance[2][3]. Key details: - FTLP10 is a pseudogene, not a functional protein, enzyme, receptor, or known therapeutic target[2][3]. - No biological function, disease relevance, or drug interactions are attributed to FTLP10. - It is distinctly separate from the functional ferritin light chain gene (FTL), which has well-described roles in iron metabolism and disease, but FTLP10 itself does not share these properties[1][4]. Therefore, while FTLP10 appears similar in name to important genes involved in iron metabolism, it is not itself a therapeutic, diagnostic, or research-relevant molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferritin light chain pseudogene 10 (FTLP10).